Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for Fistulizing Crohn's Disease
NCT00269841Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 1996
- Primary completion
- Feb 1998
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in Crohn's disease, sponsored by Janssen Pharmaceutical. Started May 1996; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00269841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00269841.